ASHLEY SKIPPER: Open Payments
NPI 1508305673 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,658 in 97 payments from 28 companies in 2025. Trend: 2023 $2,501 · 2024 $1,896 · 2025 $1,658
Food & beverage: $1,658
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $201 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $181 |
| Lilly USA, LLC | 14 | $151 |
| Abbott Laboratories | 6 | $128 |
| Boston Scientific Corporation | 1 | $120 |
| Exact Sciences Corporation | 7 | $111 |
| Dexcom, Inc. | 5 | $82 |
| ABBVIE INC. | 4 | $79 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| PFIZER INC. | 4 | $64 |
Products named: ENTYVIO, Wegovy, WATCHMAN, FREESTYLE LIBRE 3, JARDIANCE, Dexcom G6 Transmitter, MOUNJARO, The Cologuard Plus Collection Kit.
Industry payments across NY — which companies pay providers there.
